Abstract
The development of radioligand binding technique during the past decade has led to increased understanding of the cascade of events in hormone-receptor coupling and receptor-mediated signal-transducing processes [14].
This work was supported by a grant from the Deutsche Forschungsgemeinschaft. We are indebted to the Robert-Pfleger-Stiftung for generous gift of the Packard Tri-Carb and the Hewlett-Packard computer and to the Paul- and Cilli-Weill-Stiftung for the filtration device.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brodde OE, Engel G, Hoyer D, Bock KD, Weber F (1981) The β-adrenergic receptor in human lymphocytes: Subclassification by the use of a new radioligand, (±)-125Iodocyanopindolol. Life Sci 29: 2189–2198
Brodde OE, Anlauf M, Graben N, Bock KD (1982 a) In vitro and in vivo down-regulation of human platelet α2-adrenoceptors by clonidine. Eur J Clin Pharmacol 23: 403–409
Brodde OE, Anlauf M, Graben N, Bock KD (1982b) Age-dependent decrease of a2-adrenergic receptor number in human platelets. Eur J Pharmacol 81: 345–347
Bylund DB, U’Prichard DC (1983) Characterization of alpha-1 and alpha-2 adrenergic receptors. Int Rev Neurobiol 24: 343–431
Cambridge D (1981) UK-14,304, a potent and selective a 2-agonist for the characterisation of α -adrenoceptor subtypes. Eur J Pharmacol 72: 413–415
Daiguji M, Meltzer HY, Tong C, U’Prichard DC, Young M, Kravitz H (1981) a2-Adrenergic receptors in platelet membranes of depressed patients: no change in number or 3H-yohimbine affinity. Life Sci 29: 2059–2064
Feldman HA (1972) Mathematical theory of complex ligand-binding systems at equilibrium. Some methods for parameter fitting. Anal Biochem 48: 317–338
Galant SP, Underwood S, Duriseti L, Insel PA (1978) Characterization of high-affinity β2-adrenergic receptor binding of (-)-dihydroalprenolol to human polymorphonuclear cell particulates. J Lab Clin Med 92: 613–618
Grant J A, Scrutton MC (1980) Interaction of selective α-adrenoceptor agonists and antagonists with human and rabbit blood platelets. Br J Pharmacol 71: 121–134
Heidenreich KA, Weiland GA, Molinoff PB (1982) Effects of magnesium and N-ethylmaleimide on the binding of 3H-hydroxybenzylisoproterenol to β-adrenergic receptors. J Biol Chem 257: 804–810
Hoffman BB, Michel T, Kilpatrick DM, Lefkowitz RJ, Tolbert MEM, Gilman H, Fain JN (1980) Agonist versus antagonist binding to α-adrenergic receptors. Proc Natl Acad Sci USA 77: 4569–4573
Hollister AS, Fitzgerald GA, Nadeau JH, Robertson D (1983) Acute reduction in human platelet α2-adrenoceptor affinity for agonist by endogenous and exogenous catecholamines. J Clin Invest 72: 1498–1505
Jakobs KH, Aktories H, Schultz G (1981) Inhibition of adenylate cyclase by hormones and neu-rotransmitters. Adv Cyclic Nucleotide Res 14: 173–187
Lamble JW, Abbott AC (eds) (1984) Receptors, again. Elsevier, Amsterdam
Loftus DJ, Stolk JM, U’Prichard DC (1984) Binding of the imidazoline UK-14,304, a putative full α2-adrenoceptor agonist, to rat cerebral cortex membranes. Life Sci 35: 61–69
Lynch CJ, Steer ML (1981) Evidence for high and low affinity α2-receptors - Comparison of (3H)norepinephrine and (3H)phentolamine binding to human platelet membranes. J Biol Chem 256: 3298–3303
Motulsky HJ, Insel PA (1982) Adrenergic receptors in man - Direct identification, physiologic regulation, and clinical alterations. N Engl J Med 307: 18–29
Motulsky HJ, Shattil SD, Insel PA (1980) Characterisation of α2-adrenergic receptors on human platelets using (3H)yohimbine. Biochem Biophys Res Commun 97: 1562–1570
Motulsky HJ, O’Connor DT, Insel PA (1983) Platelet α2-adrenergic receptors in treated and untreated essential hypertension. Clin Sci 64: 265–272
Newman KD, Williams LT, Bishopric NH, Lefkowitz RJ (1978) Identification of α-adrenergic receptors in human platelets by (3H)dihydroergocryptine binding. J Clin Invest 61: 395–402
Perry BD, U’Prichard DC (1981) (3H)Rauwolscine (α-yohimbine): a specific antagonist radioligand for brain α2-adrenergic receptors. Eur J Pharmacol 76: 461–464
Pfeifer MA, Ward K, Malpass T, Stratton J, Halter J, Evans M, Beiter H, Harker LA, Porte D Jr (1984) Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for (3H)yohimbine or (3H)dihydroergocryptine. J Clin Invest 74: 1063–1072
Reinhardt D, Becker B, Nagel-Hiemke M, Schiffer R, Zehmisch T (1983) Influence of beta- receptor-agonists and glucocorticoids on alpha- and beta-adrenoceptors of isolated blood cells from asthmatic children. Pediatr Pharmacol (New York) 3: 293–302
Schloos J, Vogt C, Palm D (1985) Agonist-induced high-affinity state of α2-adrenoceptors of human platelets characterized by 3H-antagonist and 3H-agonist binding. Naunyn Schmiedebergs Arch Pharmacol 330 [Suppl]: R61
Smith SK, Limbird LE (1981) Solubilization of human platelet α-adrenergic receptors: Evidence that agonist occupancy of the receptor stabilizes receptor-effector interactions. Proc Natl Acad Sci USA 7: 4026–4030
Starke K (1981) α-Adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 88: 199-236
Sundaresan PR, Madan MK, Kelvie SL, Weintraub M (1985) Platelet alpha-2 adrenoceptors and the menstrual cycle. Clin Pharmacol Ther 37: 337–342
Tsai BS, Lefkowitz RJ (1979) Agonist-specific effects of guanine nucleotides on alpha-adrenergic receptors in human platelets. Mol Pharmacol 16: 61–68
U’Prichard DC, Snyder SH (1978 a) Guanyl nucleotide influences on 3H-ligand binding at α-noradrenergic receptors in calf brain membranes. J Biol Chem 253: 3444–3452
U’Prichard DC, Snyder SH (1978b) 3H-Catecholamine binding to α-receptors in rat brain: En-hancement by reserpine. Eur J Pharmacol 51: 145–155
van Meel JCA, de Jonge A, Timmermans PBMWM, van Zwieten PA (1981) Selectivity of some alpha adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normoten- sive rat. J Pharmacol Exp Ther 219: 760–767
Wellstein A, Palm D (1984) Theory of ligand-receptor interactions - Evidence for more than one site. In: Erdmann E (ed) Cardiac glycoside receptors and positive inotropy. Steinkopff, Darmstadt, pp 9–15
Wiemer G, Wellstein A, Palm D, von Hattingberg HM, Brockmeier D (1982) Properties of agonist binding at the β-adrenoceptor of the rat reticulocyte. Naunyn-Schmiedebergs Arch Pharmacol 321: 11–19
Wikberg JES (1979) The pharmacological classification of adrenergic α1 and α2 receptors and their mechanism of action. Acta Physiol Scand [Suppl] 468: 5–99
Yamamura HI, Enna SJ, Kuhar MJ (1978) Neurotransmitter receptor binding. Raven, New York
Yokoyama M, Kusui A, Sakamoto S, Fukuzaki H (1984) Age-associated increments in human platelet α-adrenoceptor capacity - Possible mechanism for platelet hyperactivity to epinephrine in aging man. Thromb Res 34: 287–295
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Schloos, J., Palm, D. (1986). Agonist Interaction with α 2-Adrenoceptors of Human Platelets. In: Middeke, M., Holzgreve, H. (eds) New Aspects in Hypertension Adrenoceptors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71418-4_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-71418-4_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-71420-7
Online ISBN: 978-3-642-71418-4
eBook Packages: Springer Book Archive